Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leiurus quinquestriatus venom toxins are a complex mixture of neurotoxic peptides produced by the Deathstalker scorpion, which are among the most potent natural toxins known (UniProt, 2024). These toxins primarily function by modulating the activity of various ion channels, including voltage-gated sodium channels, potassium channels (such as Charybdotoxin's effect on BK channels), and chloride channels (PubMed: 10692350). In the context of envenomation, these interactions lead to massive neurotransmitter release and autonomic dysfunction, which can result in fatal cardiovascular and respiratory complications (StatPearls, 2023). While the venom as a whole is a target for therapeutic neutralization via antivenoms, individual components have been harnessed for medical applications. For instance, Chlorotoxin has been developed into Tozuleristide, a tumor paint used to visualize gliomas during surgery due to its high affinity for cancer cells (PubMed: 27165443). Thus, these toxins represent both a significant clinical challenge in toxicology and a valuable resource for targeted drug development.
Antivenoms neutralize the toxins by binding to their active epitopes, preventing interaction with host ion channels (StatPearls, 2023). Toxin-derived agents like Tozuleristide utilize the specific binding affinity of Chlorotoxin for MMP-2 and Annexin A2 to deliver fluorescent markers to neoplastic tissues (PubMed: 27165443).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leiurus quinquestriatus venom toxins (LqTx).